Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses

Bruce, Douglas; Brady, John P.; Foster, Elissa; Shattell, Mona

doi:10.1089/acm.2017.0184

Cited by 41 publications

(43 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The most common form of MC consumption was inhalation (reported in 35 studies), either via smoking (joint or blunt, joint with tobacco, pipe, water pipe) or vaping (vaporizer) [34, 36, 51, 58-63, 65, 68-70, 72, 74-86, 88, 92, 94-97, 99, 101]. Reported smoking prevalence ranged from 20% [85] to 91% [59] and vaping prevalence from 7% [60] to 53% [78]. Ingested (cannabis tea, baked goods, oils, tinctures, tablets and capsules) [51, 58-61, 63, 65, 67-70, 72, 75, 76, 80-83, 85, 86, 88, 95, 97, 99] and topical administration [58,59,63,75,80,99] were less common forms of MC use (reported in 25 and 6 studies, respectively).…”

Section: Patterns Of MC Usementioning

confidence: 99%

“…Following MC use, a signi cant proportion of study participants (24% to 95%) reported considerable alleviation of pain, headache, and anxiety [34, 36, 52, 54, 55, 57, 60-65, 68, 70-73, 75-77, 80-84, 86-88, 91-97, 99] (Table 1). In addition, they perceived positive effects on mood, and an improvement of their general quality of life [18,60,65,74,82,91,96]. Participants also reported longer effects of MC with milder adverse effects, as compared to opioids and other prescription medication [34,58,67,72].…”

Section: Patterns Of MC Usementioning

confidence: 99%

“…Participants also reported longer effects of MC with milder adverse effects, as compared to opioids and other prescription medication [34,58,67,72]. The most frequently reported adverse effects were increasing appetite, drowsiness, cognitive effects, and, in case of cannabis smoking, respiratory effects [60,62,65,71,77,94,96,97]. Although in general participants considered adverse effects not severe, they had led some participants (up to 15%) to stop their MC treatment [34,51,86,95].…”

Section: Patterns Of MC Usementioning

confidence: 99%

See 2 more Smart Citations

Cannabis against chronic musculoskeletal pain: A scoping review on users and their perceptions

Furrer

Kröger

Marcotte

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Chronic musculoskeletal pain (CMP) may lead to reduced physical function and is the most common cause of chronic non cancer pain. Currently, the pharmacotherapeutic options against CMP are limited and frequently consist of pain management with non-steroidal anti-inflammatories, gabapentinoids or opioids, which carry major adverse effects. Although the effectiveness of medical cannabis (MC) for CMP still lacks solid evidence, several patients suffering from it are exploring this therapeutic option with their physicians.Objectives Little is known about MC users suffering from CMP. We aimed to increase this knowledge, useful for health care professionals and patients considering this treatment, as well as for researchers planning rigorous randomized clinical trials on the effectiveness of MC.Methods We conducted a scoping literature review, according to the methods developed by Arksey and O’Malley, to describe the views and perceptions of adult patients who had consumed MC to relieve chronic CMP. The review includes patients’ perceptions on MC against other non-cancer pain since most of the literature reports on both, as well as their demographic characteristics, patterns of MC use, and perceived positive and negative effects.Results Participants of the 49 included studies reported that MC use helped them to reduce CMP and other chronic non-cancer pain, with only minor adverse effects, and some reported improved psychological well-being.Where MC was legally available, persistent users were frequently young or middle-aged men, and the preferred form of use was smoking. The information from these studies has several methodological limitations and results are exploratory.Conclusion MC users suffering from CMP or other chronic non-cancer pain, perceived more benefits than harms. However, these user reported experiences must be examined by well-designed and methodologically sound clinical or observational studies, particularly regarding CMP, since reports on CMP are very scarce.

show abstract

Section: Patterns Of MC Usementioning

confidence: 99%

Section: Patterns Of MC Usementioning

confidence: 99%

Section: Patterns Of MC Usementioning

confidence: 99%

See 1 more Smart Citation

Cannabis against chronic musculoskeletal pain: A scoping review on users and their perceptions

Furrer

Kröger

Marcotte

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…On reviewing the published literature in detail, we found 3 previously published case reports over the last two decades, detailing 4 patient cases of adults using cannabis to reduce uncontrolled seizures . We also found 1 case series study, 7 RCTs, 1 observational study and 5 surveys examining the efficacy and safety of cannabis use in epilepsy. (Table S1) These studies showed a reduction or complete freedom from seizures following the use of CBD compared with placebo.…”

Section: Case Descriptionmentioning

confidence: 99%

Cannabinoids for drug‐resistant seizures in a critically ill patient—Case report and literature review

et al. 2019

View full text Add to dashboard Cite

What is known and objective Drug‐resistant seizures are life‐threatening and contribute to sustained hospitalization. We present the case of a critically ill 28‐year‐old male with Lennox‐Gastaut syndrome who had approximately 30 seizures/day in the intensive care unit. Case description Patient required mechanical ventilation and pharmacologically induced thiopentone coma. He was commenced on cannabidiol and subsequently extubated. He remained seizure‐free thereafter on a combination of cannabidiol and anti‐epileptic medication that predated his critical illness. What is new and Conclusion Our case report provides a unique perspective on the role of cannabidiol in achieving remission from drug‐resistant seizures in critically ill patients.

show abstract

“…3 In the absence of established clinical guidelines that stem from the paucity of clinical trial testing of MC products on the market, the adoption of MC as a therapy to manage symptoms associated with various chronic conditions continues to proliferate as an alternative or complementary method vis-àvis prescription medications. [4][5][6] To date, gender-related differences in MC use are not widely reported, and little is known about physicians' support of patients' use of MC to address symptoms associated with chronic conditions.…”

Section: Introductionmentioning

confidence: 99%

Gender Differences in Medical Cannabis Use: Symptoms Treated, Physician Support for Use, and Prescription Medication Discontinuation

Bruce

Grove

Foster

et al. 2021

Journal of Women's Health

Self Cite

View full text Add to dashboard Cite

Background: Medical cannabis (MC) utilization continues to expand in the United States, as a growing body of evidence supports the use of cannabis and cannabinoids in the treatment of a range of chronic conditions. To date, gender-related differences in MC use are not widely reported, and little is known regarding physicians' support of patients' use of MC to address symptoms associated with chronic conditions. Materials and Methods: We conducted a cross-sectional online survey of MC users in Illinois (n = 361). We summarized participants' qualifying conditions, symptoms treated with MC, perceived physician support for MC use, use of MC and prescription medications, then analyzed differences by participant gender. Results: Bivariate analyses indicate that men report higher levels of support for MC use from both specialist and primary care physicians. Women were significantly more likely to increase use of cannabis after acquiring an MC card, and to discontinue prescription medications through MC use. Multivariable analyses indicate that being a woman, using MC to treat multiple symptoms, and reporting higher levels of support for MC use from a primary care provider significantly increased the likelihood of discontinuing prescription medication through MC use. Discussion: Women are more likely to report decreased use of prescription medications to treat symptoms, and report lower levels of support from physicians for MC use. Future research on gender differences in this population may benefit from more detailed data related to symptomology, utilization, dosing, and outcomes associated with MC, and interactions with the health care system to extend these findings.

show abstract

Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses

Cited by 41 publications

References 26 publications

Cannabis against chronic musculoskeletal pain: A scoping review on users and their perceptions

Cannabis against chronic musculoskeletal pain: A scoping review on users and their perceptions

Cannabinoids for drug‐resistant seizures in a critically ill patient—Case report and literature review

Gender Differences in Medical Cannabis Use: Symptoms Treated, Physician Support for Use, and Prescription Medication Discontinuation

Contact Info

Product

Resources

About